As a response to the growth of the domestic pharmaceutical market, including the advance of Russian companies as well as international players, Egorov Puginsky Afanasiev & Partners have set up a practice dedicated to the legal support of pharmaceutical companies. The pharma industry is attracting an increasing amount of attention from the state, which is evident from the growing number of statutory acts regulating the industry, as well as more elaborate strategies to stimulate national production of pharmaceuticals (e.g. Pharma 2020).
Our experience of working with major Russian and foreign pharmaceutical companies allows us to utilize the unique skill-set of our specialists to form teams capable of executing assignments of the broadest nature and complexity.
One of the key capabilities of the practice is the legal assistance in conducting internal investigations to identify risks of violations of Russian legislation on the fight against corruption, as well as the relevant provisions of the law of foreign countries, particularly the US (FCPA) and the UK (UK Anti-Bribery Act).